Loading
SEC Form 13F · Q2 2026
Hillhouse Capital (HHLR) portfolio
Zhang Lei · HHLR ADVISORS, LTD. · CIK 0001762304
Latest 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026, compared with the quarter ended Mar 31, 2026.
Reported 13F value$832.1M
Holdings35
Top 10 concentration85.7%
New positions6
Added to6
Reduced7
Closed9
What changed in Q2 2026
Estimated trade value from reported units and period-end values
New positions
Added to
Reduced
Closed
Holdings, Q2 2026
35 positions by reported value
| Holding | Portfolio weight | Reported value | Shares / units | Change vs prior quarter |
|---|---|---|---|---|
| LEGNLEGEND BIOTECH CORP · SPONSORED ADS | 20.77% | $172.8M | 5,984,550 | Unchanged |
| FUTUFUTU HLDGS LTD · SPON ADS CL A | 19.92% | $165.8M | 1,768,283 | +24.6% |
| AVBPARRIVENT BIOPHARMA INC · COM | 16.40% | $136.5M | 3,929,117 | Unchanged |
| MRVLMARVELL TECHNOLOGY INC · COM | 5.83% | $48.5M | 162,933 | -4.7% |
| VIPSVIPSHOP HLDGS LTD · SPONSORED ADS A | 5.53% | $46.0M |
Source: SEC Form 13F filings (latest filing on sec.gov). Information and analytics, not investment advice. Holdings are reported as of the quarter end, not live positions; reported 13F value covers securities listed on Form 13F and is not the fund's total assets under management.